This announcement is a separate document:
蓝帆医疗：摩根士丹利证券（中国）有限公司、中信证券股份有限公司关于蓝帆医疗股份有限公司2023年年报问询函回复的核查意见
Blue Sail Medical: Verification opinion on the reply to the 2023 annual report inquiry letter from Blue Sail Medical Co., Ltd. by Morgan Stanley (China) Securities Limited and CITIC Securities Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.